| | | | | | | | | | |
|
|
| Dockets Entered
On January 16, 2007
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
|
|
| 2003V-0125
|
| Infrared Laser Aiming Device
|
|
|
| 2004P-0315
|
| Switch Pseudoephedrine from Over the Counter (OTC) Sales
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| 2005N-0403
|
| Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
| 2006E-0252
|
| Patent Extension Application for LEVEMIR insulin detemir (rDNA origin) injection, U.S. Patent No. 5,750,497
|
|
|
| 2006E-0261
|
| Patent Extension Application for EXJADE (deferasirox), U.S. Patent No. 6,465,504
|
|
|
| 2006E-0355
|
| Patent Extension Application for AMITIZA (lubiprostone), U.S. Patent No. 5,284,858
|
|
|
| 2006N-0061
|
| Charging for Investigational Drugs
|
|
|
| 2006N-0062
|
| Expanded Access to Investigational Drugs for Treatment Use
|
|
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
| 2006P-0438
|
| ANDA for Betamethasone Valerate Foam (non-aerosol), 0.12%
|
|
|
| 2006P-0524
|
| Withdrawal of Approval of and recall all available stock of Ziana
|
|
|
| 2007M-0006
|
| P050037 - Radiesse, 1.3cc and 0.3cc
|
|
|
| 2007M-0007
|
| P050052 - Radiesse, 1.3cc and 0.3cc
|
|
|
| 2007P-0022
|
| to permit an ANDA Suitability for Oral Transmucosal Fentanyl Cirate
|
|
|
| 2007P-0023
|
| Modify the in vitro breakpoints for penicillin and Streptococcus pneumoniae originally set by Clinical and Laboratory Standards Institute
|
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
|
|
| C 55
|
| M. Friese
|
| Vol #:
|
| 9
|
|
|
| 2003V-0125
|
| Infrared Laser Aiming Device
|
|
|
| VRA 2
|
| FDA/CDRH to Insight Technology, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004P-0315
|
| Switch Pseudoephedrine from Over the Counter (OTC) Sales
|
|
|
| PDN 1
|
| FDA/ORA to Pharmacists Planning Service Inc (PPSI)
|
| Vol #:
|
| 1
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| CS 21
|
| FDA/DDM
|
| Vol #:
|
| 240
|
|
|
| OR 21
|
| FDA/Administrative Law Judge
|
| Vol #:
|
| 240
|
|
|
| RMO 10
|
| FDA/CDRH/OGC
|
| Vol #:
|
| 240
|
|
|
| 2005N-0403
|
| Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
|
|
|
|
|
|
| C 14
|
| Allergy Laboratories, Inc.
|
| Vol #:
|
| 3
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
|
|
|
| | | | | | | |
|
|
| C 765
|
| 131 signatures
|
| Vol #:
|
| 37
|
|
|
| C 766
|
| A. Musavero
|
| Vol #:
|
| 37
|
|
|
| C 767
|
| J. Hogan
|
| Vol #:
|
| 37
|
|
|
| C 768
|
| R. Tissot
|
| Vol #:
|
| 37
|
|
|
| C 769
|
| R and M Lindenfelser
|
| Vol #:
|
| 37
|
|
|
| C 770
|
| T. Dygert
|
| Vol #:
|
| 37
|
|
|
| C 771
|
| 7 signatures
|
| Vol #:
|
| 37
|
|
|
| C 772
|
| A. Trew
|
| Vol #:
|
| 37
|
|
|
| C 773
|
| B. Kelly
|
| Vol #:
|
| 37
|
|
|
| C 774
|
| D and R Marsala
|
| Vol #:
|
| 37
|
|
|
| C 775
|
| H. Petullo
|
| Vol #:
|
| 37
|
|
|
| C 776
|
| M. Harrison
|
| Vol #:
|
| 37
|
|
|
| C 777
|
| F. Kelly et al
|
| Vol #:
|
| 37
|
|
|
| C 778
|
| S. Moxley
|
| Vol #:
|
| 37
|
|
|
| C 779
|
| S. Burnet
|
| Vol #:
|
| 37
|
|
|
| C 780
|
| F. Battle
|
| Vol #:
|
| 37
|
|
|
| C 781
|
| M. Bliss
|
| Vol #:
|
| 37
|
|
|
| C 782
|
| M. Bria
|
| Vol #:
|
| 37
|
|
|
| C 783
|
| R. Halverson
|
| Vol #:
|
| 37
|
|
|
| C 784
|
| J. Karlovitz
|
| Vol #:
|
| 37
|
|
|
| C 785
|
| E. Leaf
|
| Vol #:
|
| 37
|
|
|
| C 786
|
| C and W Clark
|
| Vol #:
|
| 37
|
|
|
| C 787
|
| T. Vaught
|
| Vol #:
|
| 37
|
|
|
| C 788
|
| A. Collins
|
| Vol #:
|
| 37
|
|
|
| C 789
|
| A. Pureill
|
| Vol #:
|
| 37
|
|
|
| C 790
|
| H. Meany
|
| Vol #:
|
| 37
|
|
|
| C 791
|
| A and G Todd
|
| Vol #:
|
| 37
|
|
|
| C 792
|
| J. Liston
|
| Vol #:
|
| 37
|
|
|
| C 793
|
| J. Neumann
|
| Vol #:
|
| 37
|
|
|
| C 794
|
| A. BAttle
|
| Vol #:
|
| 37
|
|
|
| C 795
|
| A. Barta
|
| Vol #:
|
| 37
|
|
|
| C 796
|
| T. Bressler
|
| Vol #:
|
| 37
|
|
|
| C 797
|
| K. Sommers
|
| Vol #:
|
| 37
|
|
|
| C 798
|
| D. Opferman
|
| Vol #:
|
| 37
|
|
|
| C 799
|
| P. Messina
|
| Vol #:
|
| 37
|
|
|
| C 800
|
| R. Bushmaker
|
| Vol #:
|
| 37
|
|
|
| C 801
|
| K. Kols
|
| Vol #:
|
| 37
|
|
| | | | | | | |
|
|
| C 802
|
| R. Curley
|
| Vol #:
|
| 37
|
|
|
| C 803
|
| L. Fullenjonk
|
| Vol #:
|
| 37
|
|
|
| C 804
|
| D. Foley
|
| Vol #:
|
| 37
|
|
|
| C 805
|
| F. Ollerenshaw
|
| Vol #:
|
| 37
|
|
|
| C 806
|
| E. Carlton
|
| Vol #:
|
| 37
|
|
|
| C 807
|
| Dr. P. Klump, DDS
|
| Vol #:
|
| 37
|
|
|
| C 808
|
| L. Persson
|
| Vol #:
|
| 37
|
|
|
| C 809
|
| B and C McCarthy
|
| Vol #:
|
| 37
|
|
|
| C 810
|
| B. Persson
|
| Vol #:
|
| 37
|
|
|
| C 811
|
| Illigible
|
| Vol #:
|
| 37
|
|
|
| C 812
|
| C. Martin
|
| Vol #:
|
| 37
|
|
|
| C 813
|
| M. Kemper
|
| Vol #:
|
| 37
|
|
|
| C 814
|
| M. O'Grady
|
| Vol #:
|
| 37
|
|
|
| C 815
|
| S and A Craig
|
| Vol #:
|
| 37
|
|
|
| C 816
|
| S Martensen
|
| Vol #:
|
| 37
|
|
|
| C 817
|
| P. Thayer
|
| Vol #:
|
| 37
|
|
|
| C 818
|
| L. Pillar
|
| Vol #:
|
| 37
|
|
|
| C 819
|
| D. Nichols
|
| Vol #:
|
| 37
|
|
|
| C 820
|
| 32 signatures
|
| Vol #:
|
| 37
|
|
|
| C 821
|
| L and C Yeary
|
| Vol #:
|
| 38
|
|
|
| C 822
|
| L. Favreau
|
| Vol #:
|
| 38
|
|
|
| C 823
|
| M. Hurley, OP
|
| Vol #:
|
| 38
|
|
|
| C 824
|
| D. Frame
|
| Vol #:
|
| 37
|
|
|
| C 825
|
| M. Cortney, CPA, CIA
|
| Vol #:
|
| 37
|
|
|
| C 826
|
| T. Castilanes
|
| Vol #:
|
| 37
|
|
|
| C 827
|
| J. Howland, MD
|
| Vol #:
|
| 37
|
|
|
| C 828
|
| M. Diedospiol
|
| Vol #:
|
| 37
|
|
|
| C 829
|
| G. Trevaskis
|
| Vol #:
|
| 37
|
|
|
| C 830
|
| L. Pototschnik
|
| Vol #:
|
| 37
|
|
|
| C 831
|
| National Catholic Bioethics Center
|
| Vol #:
|
| 37
|
|
|
| C 832
|
| W. Raiser
|
| Vol #:
|
| 38
|
|
|
| C 833
|
| Children of God for Life
|
| Vol #:
|
| 37
|
|
|
| C 834
|
| R. Castilano
|
| Vol #:
|
| 38
|
|
|
| C 835
|
| M. Schultz
|
| Vol #:
|
| 37
|
|
|
| C 836
|
| M. Faiola
|
| Vol #:
|
| 37
|
|
|
| C 837
|
| K. Cuzzola
|
| Vol #:
|
| 37
|
|
|
| C 838
|
| S. Sanlhez
|
| Vol #:
|
| 38
|
|
| | | | | | | |
|
|
| C 839
|
| No siganture
|
| Vol #:
|
| 38
|
|
|
| C 840
|
| B. Broader
|
| Vol #:
|
| 38
|
|
|
| C 841
|
| 2 signatures
|
| Vol #:
|
| 38
|
|
|
| C 842
|
| 2 signatures
|
| Vol #:
|
| 38
|
|
|
| C 843
|
| K and B Moran
|
| Vol #:
|
| 38
|
|
|
| C 844
|
| C. Pawelski
|
| Vol #:
|
| 38
|
|
|
| C 845
|
| 55 signatures
|
| Vol #:
|
| 38
|
|
|
| C 846
|
| J. Betlach
|
| Vol #:
|
| 38
|
|
|
| C 847
|
| D. Thimons
|
| Vol #:
|
| 38
|
|
|
| C 848
|
| 407 signatures
|
| Vol #:
|
| 38
|
|
|
| C 849
|
| T. Tabel
|
| Vol #:
|
| 38
|
|
|
| C 850
|
| 151 signatures
|
| Vol #:
|
| 38
|
|
|
| C 851
|
| 27 signatures
|
| Vol #:
|
| 38
|
|
|
| C 852
|
| 175 signatures
|
| Vol #:
|
| 38
|
|
|
| C 853
|
| J Gustke et al
|
| Vol #:
|
| 37
|
|
|
| C 854
|
| 6 signatures
|
| Vol #:
|
| 38
|
|
|
| C 855
|
| G. Lallement
|
| Vol #:
|
| 38
|
|
|
| C 856
|
| 16 signatures
|
| Vol #:
|
| 38
|
|
|
| C 857
|
| 6 signatures
|
| Vol #:
|
| 38
|
|
|
| C 858
|
| S. Reilly
|
| Vol #:
|
| 38
|
|
|
| C 859
|
| C. Niedos
|
| Vol #:
|
| 38
|
|
|
| C 860
|
| 8 signatures
|
| Vol #:
|
| 38
|
|
|
| C 861
|
| K. Maggio, M.D.
|
| Vol #:
|
| 38
|
|
|
| C 862
|
| D and A O'Connor
|
| Vol #:
|
| 38
|
|
|
| C 863
|
| E. Hurley
|
| Vol #:
|
| 38
|
|
|
| C 864
|
| J. Anzelmo
|
| Vol #:
|
| 38
|
|
|
| C 865
|
| A. Shaw
|
| Vol #:
|
| 38
|
|
|
| C 866
|
| A. Morabito
|
| Vol #:
|
| 38
|
|
|
| C 867
|
| E. Blonski
|
| Vol #:
|
| 38
|
|
|
| C 868
|
| Misty
|
| Vol #:
|
| 38
|
|
|
| C 869
|
| V and J Sanctafamilia
|
| Vol #:
|
| 38
|
|
|
| C 870
|
| K and C DeCeault
|
| Vol #:
|
| 38
|
|
|
| C 871
|
| E. Bauer
|
| Vol #:
|
| 38
|
|
|
| C 872
|
| M. Carpenter
|
| Vol #:
|
| 38
|
|
|
| C 873
|
| J. Hogan
|
| Vol #:
|
| 38
|
|
|
| C 874
|
| 10 signatures
|
| Vol #:
|
| 38
|
|
|
| C 875
|
| 6 signatures
|
| Vol #:
|
| 38
|
|
| | | | | | | | |
|
|
| C 876
|
| J and D Bibb
|
| Vol #:
|
| 38
|
|
|
| C 877
|
| J. Mattiace
|
| Vol #:
|
| 38
|
|
|
| C 878
|
| C. Webb
|
| Vol #:
|
| 38
|
|
|
| C 879
|
| 5 signatures
|
| Vol #:
|
| 38
|
|
|
| C 880
|
| B and J Smith
|
| Vol #:
|
| 38
|
|
|
| C 881
|
| Florida Catholic Conference
|
| Vol #:
|
| 38
|
|
|
| C 882
|
| J. Kucia
|
| Vol #:
|
| 38
|
|
|
| C 883
|
| M. Dibling
|
| Vol #:
|
| 38
|
|
|
| C 884
|
| L. Poteet
|
| Vol #:
|
| 38
|
|
|
| C 885
|
| 4 signatures
|
| Vol #:
|
| 38
|
|
|
| C 886
|
| L. Jones
|
| Vol #:
|
| 38
|
|
|
| C 887
|
| R and R Dufour
|
| Vol #:
|
| 38
|
|
|
| C 888
|
| No signature
|
| Vol #:
|
| 38
|
|
|
| C 889
|
| J. Weaver
|
| Vol #:
|
| 38
|
|
|
| C 890
|
| B. Grites
|
| Vol #:
|
| 38
|
|
|
| C 891
|
| L. Martineau
|
| Vol #:
|
| 38
|
|
|
| C 892
|
| K. Makara
|
| Vol #:
|
| 38
|
|
|
| C 893
|
| J. Donnelly
|
| Vol #:
|
| 38
|
|
|
| C 894
|
| K. Novcaski
|
| Vol #:
|
| 38
|
|
|
| C 895
|
| No signature
|
| Vol #:
|
| 38
|
|
|
| C 896
|
| A. Meffert
|
| Vol #:
|
| 38
|
|
|
| C 897
|
| Mary M.
|
| Vol #:
|
| 38
|
|
|
| C 898
|
| S. Lesnar
|
| Vol #:
|
| 38
|
|
|
| C 899
|
| S. Kinserski
|
| Vol #:
|
| 38
|
|
|
| 2006E-0252
|
| Patent Extension Application for LEVEMIR insulin detemir (rDNA origin) injection, U.S. Patent No. 5,750,497
|
|
|
| LET 3
|
| U.S. Patent and Trademark Office to FDA/CDER (HFD-7)
|
| Vol #:
|
| 1
|
|
|
| 2006E-0261
|
| Patent Extension Application for EXJADE (deferasirox), U.S. Patent No. 6,465,504
|
|
|
| LET 3
|
| U.S. Patent and Trademark Office to FDA/CDER (HFD-7)
|
| Vol #:
|
| 1
|
|
|
| 2006E-0355
|
| Patent Extension Application for AMITIZA (lubiprostone), U.S. Patent No. 5,284,858
|
|
|
| LET 3
|
| U.S. Patent and Trademark Office to FDA/CDER (HFD-7)
|
| Vol #:
|
| 1
|
|
|
| 2006N-0061
|
| Charging for Investigational Drugs
|
|
|
| C 1
|
| UnitedHealth Group
|
| Vol #:
|
| 1
|
|
|
| 2006N-0062
|
| Expanded Access to Investigational Drugs for Treatment Use
|
|
|
| C 3
|
| UnitedHealthcare Group
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
| C 42
|
| E. Donohoe
|
| Vol #:
|
| 5
|
|
|
| 2006P-0438
|
| ANDA for Betamethasone Valerate Foam (non-aerosol), 0.12%
|
|
|
| C 2
|
| Connetics Corporation (Connetics)
|
| Vol #:
|
| 1
|
|
|
| 2006P-0524
|
| Withdrawal of Approval of and recall all available stock of Ziana
|
|
|
| LET 1
|
| Medicis Pharmaceutical Corporation
|
| Vol #:
|
| 1
|
|
|
| 2007M-0006
|
| P050037 - Radiesse, 1.3cc and 0.3cc
|
|
|
| AAV 1
|
| BioForm Medical, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2007M-0007
|
| P050052 - Radiesse, 1.3cc and 0.3cc
|
|
|
| AAV 1
|
| BioForm Medical, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2007P-0022
|
| to permit an ANDA Suitability for Oral Transmucosal Fentanyl Cirate
|
|
|
| ACK 1
|
| FDA /DDM to Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
| CP 1
|
| Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2007P-0023
|
| Modify the in vitro breakpoints for penicillin and Streptococcus pneumoniae originally set by Clinical and Laboratory Standards Institute
|
|
|
| ACK 1
|
| FDA/DDM to Victor L. Yu, M.D.
|
| Vol #:
|
| 1
|
|
|
| CP 1
|
| Victor L. Yu, M.D.
|
| Vol #:
|
| 1
|
|
|